These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18689014)

  • 1. [Effectiveness of nootropil in the treatment of patients with cerebral stroke].
    Gusev EI; Bogolepova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):82-6. PubMed ID: 18689014
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does treatment with piracetam in stroke patients with aphasia make sense?].
    Schmidtke K
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2636. PubMed ID: 12469280
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic efficacy of nootropil different doses in attention deficit hyperactivity disorder].
    Zavadenko NN; Suvorinova SIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(3):32-7. PubMed ID: 15071842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piracetam--an old drug with novel properties?
    Winnicka K; Tomasiak M; Bielawska A
    Acta Pol Pharm; 2005; 62(5):405-9. PubMed ID: 16459490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Piracetam treatment in ischemic stroke].
    Tomczykiewicz K; Domzał T
    Neurol Neurochir Pol; 1997; 31(6):1101-9. PubMed ID: 9591298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dyslexia: clinical, neurophysiological and neuropsychological manifestations during the treatment with nootropil].
    Zavadenko NN; Rumiantseva MV; Tolstova VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):36-42. PubMed ID: 19491817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piracetam in the treatment of acute stroke.
    Orgogozo JM
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():25-32. PubMed ID: 10338105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents.
    Zavadenko NN; Guzilova LS
    Neurosci Behav Physiol; 2009 May; 39(4):323-8. PubMed ID: 19340573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The functional-morphological characteristics of alcohol-induced pathology as dependent on the nature of the intoxication and its nootropil correction in an experiment].
    Sidorov PI; Gromova LE; Solov'ev AG; Degteva GN; Leont'ev VIa; Savastenko AE
    Patol Fiziol Eksp Ter; 2000; (3):17-9. PubMed ID: 10983474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peculiarities of treatment of asthenic syndrome in the acute period of ischemic stroke].
    Kalinskiĭ PP; Nazarov VV; Samarets NA; Ulitina MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):72-4. PubMed ID: 18800418
    [No Abstract]   [Full Text] [Related]  

  • 11. Piracetam therapy for Down syndrome: a rush to judgment?
    Black SL
    Arch Pediatr Adolesc Med; 2001 Oct; 155(10):1176; author reply 1177-8. PubMed ID: 11576019
    [No Abstract]   [Full Text] [Related]  

  • 12. Piracetam: a novel therapy for autism?
    Paczynski M
    J Autism Dev Disord; 1997 Oct; 27(5):628-30. PubMed ID: 9403377
    [No Abstract]   [Full Text] [Related]  

  • 13. Piracetam for Sialorrhea in 2 Children With Intellectual Disability.
    Bozkurt H
    J Clin Psychopharmacol; 2015 Oct; 35(5):621-2. PubMed ID: 26252441
    [No Abstract]   [Full Text] [Related]  

  • 14. Piracetam study: poorly designed and misinterpreted.
    Croom J
    Arch Pediatr Adolesc Med; 2001 Oct; 155(10):1176-8. PubMed ID: 11576020
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of piracetam in vertigo].
    Mantsev EI; Sigaleva EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):90-4. PubMed ID: 19908411
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of piracetam in the treatment of acute and chronic aphasia.
    Huber W
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():38-43. PubMed ID: 10338107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of neurotropic and stress-protective properties of piracetam and the derivative pyrido]1,2-a]pyrimidine].
    Kozlovskaia MM; Inozemtsev AN; Nikitin SV; Gochmuradov AG; Iakushev RA; Chabak-Gorbach R
    Biull Eksp Biol Med; 1995 Mar; 119(3):299-301. PubMed ID: 7795202
    [No Abstract]   [Full Text] [Related]  

  • 18. [Piracetam, nimodipine and tacrine in the pharmacologic treatment of dementia: bibliographic review].
    Ojer Tsakiridu D; Dosantos Hernández JO; Larrabe Medina J; Sánchez Casado JI; Sologuren Echenagusia A
    Aten Primaria; 1996 Sep; 18(5):257-60, 262-4. PubMed ID: 8936720
    [No Abstract]   [Full Text] [Related]  

  • 19. [Atomoxetine and piracetam in the treatment of attention deficit hyperactivity disorder in children].
    Zavadenko NN; Suvorinova NIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(7):43-7. PubMed ID: 18833117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piracetam treatment in patients with cognitive impairment.
    Rao MG; Holla B; Varambally S; Raveendranathan D; Venkatasubramanian G; Gangadhar BN
    Gen Hosp Psychiatry; 2013; 35(4):451.e5-6. PubMed ID: 22763000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.